Boeing Shares Take a 4.5% Dive as China Halts Jet Deliveries Amid Rising Trade Tensions
Boeing's stock drops 4.5% after China orders airlines to suspend new jet deliveries, amid heightened US-China trade tensions and US tariffs on Chinese products.
Business News
TDK Unveils Revolutionary 'Spin Photo Detector' Technology Set to Transform AI and Data Centers
TDK Corporation announces its 'Spin Photo Detector' technology, a potential game-changer for the AI and data center industries, offering ultra-high-speed optical detection and over...
Honda Considers Shifting Production to US Amid Trump's Tariff Threats on Non-US Made Cars
Honda Motor Co., Ltd. is considering moving its car production from Mexico and Canada to the US in response to Trump's 25% tariff on non-US made cars, aiming to meet 90% of US sale...
American Airlines Unveils Free Wi-Fi for AAdvantage Members Starting January 2026
American Airlines announces free Wi-Fi for AAdvantage members on 90% of its fleet starting January 2026, in partnership with AT&T, Viasat, and Intelsat, enhancing in-flight connect...
Johnson & Johnson Q1 Earnings Soar: Sales Hit $21.9 Billion with a 2.4% Increase
Johnson & Johnson announced a 2.4% increase in Q1 sales to $21.9 billion, exceeding expectations. Earnings per share and net earnings saw significant growth, with leadership expres...
Bank of America Surges Ahead with an 11% Jump in Q1 Net Income to $7.4B, Beating Expectations
Bank of America announces an 11% increase in Q1 net income to $7.4B, with diluted earnings per share up by 18% to $0.90. Revenue grows by 6% to $27.4B, exceeding expectations. CEO ...
India Aims to Surpass China and Brazil, Becoming the World's Second Largest Iron Ore Producer
India is set to become the world's second-largest iron ore producer, surpassing China and Brazil, with a potential annual production of 700 million tonnes. This growth promises sig...
Biocon Biologics Secures Landmark Deal to Launch Yesafili, a Breakthrough Biosimilar, in the US Market
Biocon Biologics has reached a landmark agreement with Regeneron to commercialize Yesafili, a biosimilar to Eylea, in the US by 2026, following FDA approval. This deal resolves leg...
Popular News
